ラパリズム錠1mg e-learning

関連文献リスト

患者向け資材

学会・講演会情報

nobel_park_logo

メドピア

カスタマーセンター

トピックス

  1. ホーム > 
  2. トピックス
MP604 | DOES EARLY INTERVENTION BENEFIT PATIENTS
WITH LAM?

Session Info: Meet the Professor Seminar, [MP604] DOES EARLY INTERVENTION BENEFIT PATIENTS WITH LAM?

Learning Objective 1: be able to understand cellular and molecular mechanisms and clinical features of

lymphangioleiomyomatosis

Learning Objective 2: learn how effective it will be in practice when the patients with LAM are treated with sirolimus

Learning Objective 3: learn when and what kinds of adverse effects you should take care in the treatment

Day/Date: Tuesday, May 19, 2015

Session Time: 12:15 PM - 1:15 PM

Room: Mineral Hall D (Third Floor)

Location: Hyatt Regency Denver at CCC

Speakers: K. Nakata, MD, PhD, T. Takada, MD, PhD

Niigata/JP

ページのトップへ

サイトマップ    個人情報保護方針    著作権について    ご利用にあたって

© 2017.Nobelpharma Co., Ltd. all right reserved.